Clinical Trials conducted in emerging regions have expanded to include more countries. Among these newly emerging countries, Greece and Turkey have shown exponential growth in foreign-sponsored Clinical Trials. Greece is an EU member and part of Eurozone. Turkey has a geographic proximity to Europe. Greece and Turkey show successful patient recruitment rates, presence of highly skilled Investigators and reduced clinical research costs. Greece and Turkey have in total a population of more than 85 million people offering high recruitment potential. Most clinical sites in Greece and Turkey are located in universities and specialized hospitals in the big cities. These institutions offer access to a large pool of eligible subjects which greatly facilitates patient recruitment. Clinical Trials in Greece and Turkey are conducted in several therapeutic areas, including a number of rare diseases as well as diseases formerly prevalent in more developed countries including cardiovascular diseases, diabetes, obesity, hypercholesterolemia, and several types of cancer. Population growth, increased life expectancy, urbanization, tobacco consumption, and the adoption of western dietary habits have all contributed to an increasing prevalence of these diseases in the two countries.
In order to obtain approval for a clinical trial, the study protocol must be submitted to health authorities and reviewed by an Ethics Committee.
Contract Research Organizations (CRO) are organizations that provide support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.